|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Obstetrics/Gynecology and Physiology, University of Alberta, Edmonton, AB, Canada
2 Department of Dentistry, University of Alberta, Edmonton, AB, Canada
* To whom correspondence should be addressed. E-mail: sandra.davidge{at}ualberta.ca.
Aging and estrogen deficiency increase the risk for developing cardiovascular disease (CVD). Oxidative stress has also been implicated in the pathophysiology of CVD, and in ischemia-reperfusion (I/R) injury. We tested the hypothesis that either chronic in vivo estrogen treatment or superoxide inhibition with the SOD mimetic, EUK-8, improves cardiac functional recovery after I/R in the aged female rat. Sprague Dawley rats (12-14 months) were used: Intact (n=6), Ovariectomized + Placebo (OVX, n=6), OVX + EUK-8 (EUK-8, 3mg/kg, n=6), OVX + Estrogen (E2, 1.5mg/pellet, 60 days release, n=6). Perfused isolated hearts were subjected to global ischemia (25 minutes) followed by reperfusion (40 minutes). Functional recovery after I/R and myocardial expression of NADPH oxidase (p22, p67, and gp91phox), iNOS, eNOS, and SOD1 protein expression, as well as nitrotyrosine levels (as a marker for peroxynitrite) were assessed. Compared to OVX, both EUK-8 and E2 markedly improved functional recovery following I/R that was associated with a decrease in NADPH oxidase expression and nitrotyrosine staining. However, E2 increased iNOS expression, while EUK-8 had little effect. There were no significant changes in eNOS and SOD1 expression among the groups. These results indicate that EUK-8 and E2 improved cardiac recovery following I/R. Given the controversy surrounding hormone replacement therapy, EUK-8 may be an alternative to estrogen in protecting those at risk for myocardial ischemia in the aging population.
This article has been cited by other articles:
![]() |
M. Satoh, C. M. Matter, H. Ogita, K. Takeshita, C.-Y. Wang, G. W. Dorn II, and J. K. Liao Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen Circulation, June 26, 2007; 115(25): 3197 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P.M. van Empel, A. T. Bertrand, R. J. van Oort, R. van der Nagel, M. Engelen, H. V. van Rijen, P. A. Doevendans, H. J. Crijns, S. L. Ackerman, W. Sluiter, et al. EUK-8, a Superoxide Dismutase and Catalase Mimetic, Reduces Cardiac Oxidative Stress and Ameliorates Pressure Overload-Induced Heart Failure in the Harlequin Mouse Mutant J. Am. Coll. Cardiol., August 15, 2006; 48(4): 824 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, S. J. Williams, D. O'Brien, and S. T. Davidge Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring FASEB J, June 1, 2006; 20(8): 1251 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, T. A. Doser, C. X. Fang, J. M. Nunn, R. Janardhanan, M. Zhu, N. Sreejayan, M. T. Quinn, and J. Ren Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress FASEB J, May 1, 2006; 20(7): 1024 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Arenas, Y. Xu, and S. T. Davidge Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-{alpha} antagonism Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1259 - H1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, I. A. Arenas, S. J. Armstrong, W. C. Plahta, H. Xu, and S. T. Davidge Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-{alpha} Cardiovasc Res, March 1, 2006; 69(4): 836 - 844. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |